H-Thr-Pro-Arg-Ala-Arg-Arg-Arg-Lys-Lys-Arg-Ile-NH2

InChIKey	`ALKYWGCWYLWWQX-WEOSOBNISA-N`
Compound Name	H-Thr-Pro-Arg-Ala-Arg-Arg-Arg-Lys-Lys-Arg-Ile-NH2
Canonical SMILES	`CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)C(N)=O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	6.74
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P09958	FURIN	Homo sapiens	Human	PF01483 PF00082 PF16470	7.5	Ki	ChEMBL
Q16549	PCSK7	Homo sapiens	Human	PF01483 PF00082 PF16470	6.9	Ki	ChEMBL
Q92824	PCSK5	Homo sapiens	Human	PF14843 PF01483 PF00082 PF16470	6.3	Ki	ChEMBL
Q6UW60	PCSK4	Homo sapiens	Human	PF01483 PF00082 PF16470	6.2	Ki	ChEMBL